The publications on this site are part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

Companies

Search All Companies »

Find a Company by Name

View All Companies

All
Industries

Biotechnology

Email Alert | RSS Feed

Yuhan Corp. / See Company Profile

Alliance / BI licenses Yuhan's GLP-1/FGF21 dual agonist for NASH / Strategic Transactions / Deal Date: Jul. 1, 2019 / Publish Date: Jul. 2, 2019

Alliance / Sorrento and Yuhan create immuno-oncology joint venture, ImmuneOncia / Strategic Transactions / Deal Date: Mar. 1, 2016 / Update Date: Feb. 1, 2019

Alliance / Gilead gets NASH rights from Yuhan; pays up to $785mm / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 11, 2019

Eddingpharm International Holdings Ltd. / See Company Profile

Alliance / Eddingpharm licenses thrombocytopenia drug Mulpleta from Shionogi / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 24, 2019

Alliance / Lilly sells two legacy antibiotics and manufacturing facility to Eddingpharm for $375mm / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 24, 2019

Alliance / Eddingpharm gets Asian rights to Amarin's cardiovascular drug Vascepa / Strategic Transactions / Deal Date: Feb. 1, 2015 / Publish Date: Feb. 26, 2015

Karuna Therapeutics Inc. / See Company Profile

Financing / Karuna nets $83mm in up-sized IPO / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jul. 1, 2019

Financing / Karuna brings in $68mm through its Series B round / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 19, 2019

Financing / Karuna closes $42mm Series A round to advance KarXT schizophrenia candidate / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Sep. 10, 2018


Medical Devices

Email Alert | RSS Feed

Merit Medical Systems Inc. / See Company Profile

Acquisition / Merit Medical acquires BrightWater Medical for up to $50mm / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 25, 2019

Acquisition / Cianna Medical acquired by Merit / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 3, 2018

Financing / Merit Medical nets $205.4mm through public offering / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 27, 2018

Hologic Inc. / See Company Profile

Acquisition / Hologic to acquire SuperSonic Imagine / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 26, 2019

Alliance / Hologic to sell SuperSonic Imagine's ultrasound system / Strategic Transactions / Deal Date: Nov. 1, 2010 / Update Date: Jun. 1, 2019

Acquisition / Hologic buys Focal Therapeutics for $125mm / Strategic Transactions / Deal Date: Sep. 1, 2018 / Publish Date: Oct. 3, 2018

MRI Interventions Inc. / See Company Profile

Financing / MRI Interventions closes $7.5mm PIPE with investment by PTC / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: Jun. 25, 2019

Financing / MRI Interventions brings in $13.25mm through PIPE / Strategic Transactions / Deal Date: May 1, 2017 / Publish Date: Jun. 1, 2017

Alliance / Acoustic MedSystems and MRI Interventions develop ultrasonic ablation therapies for pancreatic cancer / Strategic Transactions / Deal Date: Apr. 1, 2017 / Publish Date: May 9, 2017


In Vitro Diagnostics

Email Alert | RSS Feed

Tangen Biosciences Inc. / See Company Profile

Financing / Series A lands $9mm for Tangen Biosciences / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 24, 2019


Pharmaceuticals

Email Alert | RSS Feed

Allergan PLC / See Company Profile

Acquisition / AbbVie pays $63bn in cash and stock for Allergan / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 25, 2019

Alliance / Allergan gets option to CRISPR-based ocular programs from Editas / Strategic Transactions / Deal Date: Mar. 1, 2017 / Update Date: Apr. 1, 2019

Alliance / Allergan gets exclusive rights to Merck's CGRP program for migraine / Strategic Transactions / Deal Date: Jul. 1, 2015 / Update Date: Mar. 1, 2019

PeptiDream Inc. / See Company Profile

Alliance / Novartis, PeptiDream ally again; this time in radionuclide PDCs / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jul. 3, 2019

Alliance / PeptiDream, Santen ally in ophthalmic diseases / Strategic Transactions / Deal Date: Sep. 1, 2018 / Publish Date: Sep. 26, 2018

Alliance / Bayer and PeptiDream enter into multi-target discovery collaboration / Strategic Transactions / Deal Date: Nov. 1, 2017 / Publish Date: Nov. 22, 2017

Biohaven Pharmaceutical Holding Co. Ltd. / See Company Profile

Financing / Biohaven nets $282mm through FOPO / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 24, 2019

Financing / Biohaven buys GW Pharmaceuticals' PRV for $105mm / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 19, 2019

Financing / Biohaven completes $125mm private placement through Royalty Pharma; could get $75mm more / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 19, 2019

Biotechnology

Biotechnology

Email Alert | RSS Feed

Yuhan Corp. / See Company Profile

Alliance / BI licenses Yuhan's GLP-1/FGF21 dual agonist for NASH / Strategic Transactions / Deal Date: Jul. 1, 2019 / Publish Date: Jul. 2, 2019

Alliance / Sorrento and Yuhan create immuno-oncology joint venture, ImmuneOncia / Strategic Transactions / Deal Date: Mar. 1, 2016 / Update Date: Feb. 1, 2019

Alliance / Gilead gets NASH rights from Yuhan; pays up to $785mm / Strategic Transactions / Deal Date: Jan. 1, 2019 / Publish Date: Jan. 11, 2019

Eddingpharm International Holdings Ltd. / See Company Profile

Alliance / Eddingpharm licenses thrombocytopenia drug Mulpleta from Shionogi / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 24, 2019

Alliance / Lilly sells two legacy antibiotics and manufacturing facility to Eddingpharm for $375mm / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 24, 2019

Alliance / Eddingpharm gets Asian rights to Amarin's cardiovascular drug Vascepa / Strategic Transactions / Deal Date: Feb. 1, 2015 / Publish Date: Feb. 26, 2015

Karuna Therapeutics Inc. / See Company Profile

Financing / Karuna nets $83mm in up-sized IPO / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jul. 1, 2019

Financing / Karuna brings in $68mm through its Series B round / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 19, 2019

Financing / Karuna closes $42mm Series A round to advance KarXT schizophrenia candidate / Strategic Transactions / Deal Date: Aug. 1, 2018 / Publish Date: Sep. 10, 2018

Medical
Devices

Medical Devices

Email Alert | RSS Feed

Merit Medical Systems Inc. / See Company Profile

Acquisition / Merit Medical acquires BrightWater Medical for up to $50mm / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 25, 2019

Acquisition / Cianna Medical acquired by Merit / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 3, 2018

Financing / Merit Medical nets $205.4mm through public offering / Strategic Transactions / Deal Date: Jul. 1, 2018 / Publish Date: Jul. 27, 2018

Hologic Inc. / See Company Profile

Acquisition / Hologic to acquire SuperSonic Imagine / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 26, 2019

Alliance / Hologic to sell SuperSonic Imagine's ultrasound system / Strategic Transactions / Deal Date: Nov. 1, 2010 / Update Date: Jun. 1, 2019

Acquisition / Hologic buys Focal Therapeutics for $125mm / Strategic Transactions / Deal Date: Sep. 1, 2018 / Publish Date: Oct. 3, 2018

MRI Interventions Inc. / See Company Profile

Financing / MRI Interventions closes $7.5mm PIPE with investment by PTC / Strategic Transactions / Deal Date: May 1, 2019 / Publish Date: Jun. 25, 2019

Financing / MRI Interventions brings in $13.25mm through PIPE / Strategic Transactions / Deal Date: May 1, 2017 / Publish Date: Jun. 1, 2017

Alliance / Acoustic MedSystems and MRI Interventions develop ultrasonic ablation therapies for pancreatic cancer / Strategic Transactions / Deal Date: Apr. 1, 2017 / Publish Date: May 9, 2017

In Vitro
Diagnostics

In Vitro Diagnostics

Email Alert | RSS Feed

Tangen Biosciences Inc. / See Company Profile

Financing / Series A lands $9mm for Tangen Biosciences / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 24, 2019

Pharmaceuticals

Pharmaceuticals

Email Alert | RSS Feed

Allergan PLC / See Company Profile

Acquisition / AbbVie pays $63bn in cash and stock for Allergan / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 25, 2019

Alliance / Allergan gets option to CRISPR-based ocular programs from Editas / Strategic Transactions / Deal Date: Mar. 1, 2017 / Update Date: Apr. 1, 2019

Alliance / Allergan gets exclusive rights to Merck's CGRP program for migraine / Strategic Transactions / Deal Date: Jul. 1, 2015 / Update Date: Mar. 1, 2019

PeptiDream Inc. / See Company Profile

Alliance / Novartis, PeptiDream ally again; this time in radionuclide PDCs / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jul. 3, 2019

Alliance / PeptiDream, Santen ally in ophthalmic diseases / Strategic Transactions / Deal Date: Sep. 1, 2018 / Publish Date: Sep. 26, 2018

Alliance / Bayer and PeptiDream enter into multi-target discovery collaboration / Strategic Transactions / Deal Date: Nov. 1, 2017 / Publish Date: Nov. 22, 2017

Biohaven Pharmaceutical Holding Co. Ltd. / See Company Profile

Financing / Biohaven nets $282mm through FOPO / Strategic Transactions / Deal Date: Jun. 1, 2019 / Publish Date: Jun. 24, 2019

Financing / Biohaven buys GW Pharmaceuticals' PRV for $105mm / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 19, 2019

Financing / Biohaven completes $125mm private placement through Royalty Pharma; could get $75mm more / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 19, 2019

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel